**Core Concept**
Secondary deposits from prostatic carcinoma are a common manifestation of advanced disease, characterized by the spread of malignant cells from the prostate gland to distant sites. This phenomenon is a result of the metastatic potential of prostate cancer cells, which can invade surrounding tissues and gain access to the bloodstream or lymphatic system.

**Why the Correct Answer is Right**
Prostate cancer cells often metastasize to bone due to the high affinity of prostate-specific antigen (PSA) for bone matrix proteins. The bone microenvironment provides a fertile ground for prostate cancer cells to grow and proliferate, leading to the formation of osteoblastic metastases. This process is mediated by the interaction between PSA and its receptors on osteoblasts, promoting the activation of osteoclasts and the subsequent bone resorption. As a result, bone is the most common site of distant metastasis in patients with prostate cancer.

**Why Each Wrong Option is Incorrect**
**Option B:** Kidney is not a common site for metastasis from prostatic carcinoma, as the primary mechanism of metastasis involves the hematogenous route, which is more likely to target organs with a high vascular supply, such as the lungs, liver, and bones.

**Option C:** Liver is a site of metastasis for several types of cancer, including colorectal and breast cancer, but it is not the most common site for prostate cancer metastasis. The liver's unique anatomy and function make it less susceptible to prostate cancer metastasis.

**Option D:** Brain metastases are relatively rare in prostate cancer, accounting for only a small percentage of cases. The blood-brain barrier and the limited ability of prostate cancer cells to penetrate this barrier make it a less likely site for metastasis.

**Clinical Pearl / High-Yield Fact**
Prostate cancer metastasis to bone often leads to the development of osteoblastic lesions, which can be detected on bone scans or radiographs. A high index of suspicion and prompt bone imaging are essential for diagnosing bone metastasis in patients with prostate cancer.

**✓ Correct Answer: A. Bone**